The Methodist Hospital Research Institute

This early-stage study tested the safety of combining an existing immunotherapy drug (atezolizumab) with a new gene therapy (ADV/IL-12) for patients with advanced non-small cell lung cancer. The trial was for people whose cancer had continued to grow despite receiving standard fi…

This study tested a combination of three treatments for an aggressive type of breast cancer that had stopped responding to standard chemotherapy. It combined chemotherapy (docetaxel), an immunotherapy drug (pembrolizumab), and an experimental gene therapy designed to boost the im…

This study tested if a specific set of knee-strengthening exercises (called a knee isometric program) worked better than the usual physical therapy for reducing pain in the front of the knee. A small group of adults with knee pain were randomly assigned to try one of the two exer…

This study observed children (age 17 and under) who received a standard rabies prevention shot after an animal bite or scratch. Researchers tracked any side effects for 30 days to confirm the shot's safety in kids. The study did not test a new treatment but monitored the safety o…